Background. A self-report screening scale of adult attention-deficit/hyperactivity disorder (ADHD), the World Health Organization (WHO) Adult ADHD Self-Report Scale (ASRS) was developed in conjunction with revision of the WHO Composite International Diagnostic Interview (CIDI). The current report presents data on concordance of the ASRS and of a short-form ASRS screener with blind clinical diagnoses in a community sample.
INTRODUCTION
Although it has long been known that attentiondeficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders among children (Shekim et al. 1985; Bird et al. 1988) and that ADHD often persists into adulthood (Menkes et al. 1967 ; Mannuzza et al. 1993) , the fact that adult ADHD is a commonly occurring and seriously impairing disorder has only recently become the focus of attention (Wender et al. 2001 ; Pary et al. 2002 ; Wilens et al. 2002) . One commentator has gone so far as to suggest that ADHD is probably 'the most common chronic undiagnosed psychiatric disorder in adults ' (Wender, 1998) . However, no large-scale epidemiological data exist to evaluate this claim, as none of the many adult community psychiatric epidemiological surveys carried out over the past two decades with either the Diagnostic Interview Schedule (DIS ; Robins et al. 1981) or the Composite International Diagnostic Interview (CIDI ; Robins et al. 1988) included an assessment of adult ADHD.
Several attempts have been made to estimate the general population prevalence of adult ADHD by extrapolation from childhood prevalence estimates in conjunction with adult persistence estimates (Weiss et al. 1985; Mannuzza et al. 1998 ; Biederman et al. 2000; Barkley et al. 2002) or by direct estimation from small samples of adults (Murphy & Barkley, 1996) or college students (Heiligenstein et al. 1998) , yielding prevalence estimates in the range 1-6 %. However, these estimates are all based on convenience samples. In an effort to obtain more representative estimates, adult ADHD is included in the new World Health Organization (WHO) World Mental Health (WMH) Initiative surveys (Kessler & Ustun, 2000) , a series of general population psychiatric epidemiological surveys currently underway in 28 different countries in all regions of the world with a combined sample size of more than 200 000 respondents.
Both retrospective assessments of childhood ADHD and a screen for adult ADHD were developed for use in the expanded version of CIDI that forms the core of the WMH surveys. The retrospective assessment was part of a series of four sections devoted to adult recall of childhood disorders (oppositional-defiant disorder, conduct disorder, and separation anxiety disorder in addition to ADHD) that were based on the comparable sections in the DIS (Robins et al. 1995) . There was no precedent, though, for assessing adult ADHD in previous DIS-CIDI surveys. Although other self-report measures of adult ADHD exist (Barkley, 1995; Brown, 1996 ; Conners et al. 1998 ; Mehringer et al. 2002 ; West et al. 2003) , a review of these measures showed that they either fail to include all 18 DSM-IV Criterion A symptoms or assess some of these symptoms with questions that were judged to be suboptimal by an Advisory Group of clinical experts in adult ADHD assembled by the WHO to consult on this aspect of the WMH survey assessment. Based on this evaluation, a decision was made to develop a new self-report measure of adult ADHD for the WMH surveys. The present report describes this measure : the WHO Adult ADHD Self-Report Scale (ASRS) Version 1.1. A short ASRS screener, which turned out to outperform the full ASRS in the clinical calibration study reported here, was also developed based on stepwise logistic regression.
METHOD Participants
The clinical calibration of the ASRS was carried out by re-interviewing a quota subsample of 154 respondents from the US National Comorbidity Survey Replication (NCS-R ; Kessler et al. 2003) , a nationally representative faceto-face household survey of 9083 respondents aged 18 and older in the co-terminous United States who were interviewed by trained lay interviewers between February 2001 and December 2002. NCS-R respondents were selected from a stratified, multi-stage, clustered area probability sample of the USA non-institutionalized civilian population, with over 1000 segments (i.e. blockequivalents) in 170 counties in 34 states. The response rate among primary respondents was 70 . 9%. All respondents were administered the WMH version of the CIDI in Part I of the interview, while a probability subsample of 5692 respondents also received a Part II interview that included assessments of risk factors and other disorders. The Part II sample consisted of all respondents who screened positive for any Part I WMH-CIDI disorder plus a probability subsample of 25 % other Part I respondents. Less than 1 % of the Part I respondents who were selected into the Part II sample failed to complete Part II. This conditional response rate was unrelated to the Part II sampling stratum. A more detailed description of the NCS-R sample design and field procedures is presented elsewhere (Kessler et al. in press) .
Based on a concern that older adults would have difficulty responding to retrospective questions about childhood, the assessment of ADHD was limited to respondents in the age range 18-44 years. Respondents who reported symptoms that were classified as having met criteria for ADHD in childhood were asked a single follow-up question about whether they continued to have any current problems with attention or hyperactivity-impulsivity. The respondents who received the ADHD assessment were divided into four sampling strata for the adult ADHD clinical calibration sample: those who denied any childhood symptoms of ADHD, those who reported at least some symptoms but were classified as not meeting full criteria, those who were classified as meeting criteria but denied having current adult symptoms, and those who were classified as meeting criteria who reported having current adult symptoms.
An attempt was made to contact by telephone and re-interview 30 respondents in each of the first three strata and 60 in the fourth stratum. The final quota sample of 154 was slightly larger than the sum of these targets because a higher than expected proportion of pre-designated respondents kept their appointments to be interviewed. Before beginning the interviews, respondents were told that the purpose of the interviews was to test the accuracy and expand the measures in the original survey, that participation was completely voluntary and confidential, and that we would send respondents a check for $50 as a token of our appreciation for their participation in this phase of the research. Respondents were then allowed to ask any additional questions before obtaining verbal informed consent and beginning the interview. Interviews were tape-recorded with the permission of respondents. The Harvard Medical School Human Subjects Committee approved these recruitment and consent procedures.
Two levels of weighting were required to make the 154 respondents representative of the total NCS-R sample. First, the sample was weighted using the NCS-R Part II composite weight to adjust for differential probabilities of selection into the overall sample within households ; differences in intensity of recruitment effort among hard-to-recruit cases ; differential non-response across sample segments based on aggregated Census Block Group data ; discrepancies between the sample and the Census population distribution on the crossclassification of various sociodemographic variables ; and differential probabilities of selection into the Part II sample. The development of these weights is discussed in detail elsewhere (Kessler et al. 2003) . Second, the sample was weighted to adjust for the oversampling of Part II respondents who reported childhood ADHD and adult persistence of ADHD symptoms. It has previously been shown that the weighted NCS-R Part II sample distribution closely matches the Census population on a variety of geographic and demographic variables (Kessler et al. 2003) . The weighted ADHD clinical calibration sample distribution was found roughly to approximate the Part II NCS-R distribution on these same sociodemographic variables. (Appendix tables that include details of these comparisons along with other results that are too detailed to be reported in this paper are available at www.hcp.med.harvard.edu/ncs).
The screening scale item pool Two board-certified psychiatrists (L.A., T.S.) and the WHO advisory group of clinical experts in adult ADHD (see Acknowledgments) generated an initial pool of fully structured questions about the symptoms of ADHD as they are typically expressed among patients with adult ADHD and mapped these onto each of the 18 DSM-IV Criterion A symptoms. The survey methodology collaborators (R.C.K., T.B.U.) then modified these questions to remove doublebarreled descriptions, reduce ambiguities in meaning, and create a consistent temporal focus. The clinical collaborators then made modifications to improve face validity. One question was selected from this final item pool for each of the 18 DSM-IV Criterion A symptoms of ADHD based on face validity. Eleven more questions were selected to span the range of symptoms not in DSM-IV that were thought by the clinical experts to be common expressions of adult ADHD. Each question asked how often a symptom occurred over the past 6 months on a 0-4 scale with responses of never (0), rarely (1), sometimes (2), often (3), and very often (4). The focus of this report is on the 18 questions designed to operationalize the DSM Criterion A symptoms ( Table 1) .
The clinical interview
The clinical interview used in the calibration study had three parts. The first part was the semi-structured clinical ADHD Rating Scale (ADHD-RS ; DuPaul et al. 1998), a state-ofthe-art retrospective assessment of childhood ADHD designed for administration to adults. The second part was the semi-structured clinical interview for recent (past 6 months) DSM-IV adult ADHD that is used in most clinical trials of this disorder (Spencer et al. 1995 (Spencer et al. , 1998 (Spencer et al. , 2001 Michelson et al. 2003) . The third part was the self-report battery, which was administered at the end in order not to bias interviewers when they made their clinical symptom ratings. Four experienced clinical interviewers (Ph.D. clinical psychologists with between 5 and 20 years of clinical experience) carried out these interviews. Each interviewer received 40 hours of training from two board certified psychiatrists who specialize in research on adult ADHD (L.A., T.S.) and successfully completed five practice interviews in which their symptom ratings matched those of the trainers before they began production interviewing. Clinical supervisor (M.H.) reviewed tape recordings of clinical interviews. Discrepancies between interviewer and supervisor ratings were referred to the board certified psychiatrists (L.A., T.S.) for discussion and resolution and, as needed, additional contacts with respondents. The supervisor and clinical collaborators also held weekly group interviewer calibration meetings, while the supervisor held weekly one-onone feedback meetings with each interviewer separately. Consistent with DSM-IV criteria, a clinical diagnosis of adult ADHD required that a respondent have at least six symptoms of either inattention or hyperactivity-impulsivity during the 6 months before the interview (DSM-IV Criterion A), at least two Criterion A symptoms of ADHD before age seven (Criterion B), some impairment in at least two areas of living during the past 6 months (Criterion C), and clinically significant impairment in at least one area of living over the same time period (Criterion D) . No attempt was made to operationalize the DSM-IV diagnostic hierarchy rules for ADHD (Criterion E).
Statistical methods
Symptom-level concordance between ASRS self-reports and blind clinician ratings of 6-month prevalence was evaluated by dichotomizing the 0-4 ASRS response scale separately for each question to maximize overall classification accuracy with dichotomous clinical symptom ratings. A wide range of possible simple scoring methods that used all 18 questions was then investigated. Diagnostic efficiency statistics were calculated for each of these to select the best method, including sensitivity (the percent of respondents with the clinician-rated syndrome classified as having How often do you misplace or have difficulty finding things at home or at work ? 8.
How often are you distracted by activity or noise around you ? 9.*# How often do you have problems remembering appointments or obligations ?
II. Hyperactivity-Impulsivity 1.# How often do you fidget or squirm with your hands or your feet when you have to sit down for a long time ? 2.* How often do you leave your seat in meetings or other situations in which you are expected to remain seated ? 3.
How often do you feel restless or fidgety ? 4.
How often do you have difficulty unwinding and relaxing when you have time to yourself ? 5.# How often do you feel overly active and compelled to do things, like you were driven by a motor ? 6.
How often do you find yourself talking too much when you are in a social situation ? 7.* When you're in a conversation, how often do you find yourself finishing the sentences of the people that you are talking to, before they can finish them themselves ? 8.
How often do you have difficulty waiting your turn in situations when turn-taking is required ? 9.* How often do you interrupt others when they are busy ?
Response options are : never, rarely, sometimes, often, and very often. Patients were asked to answer the questions using a 6-month recall period.
* Clinically significant symptom levels were defined for these seven questions as responses of sometimes, often, and very often. For all remaining 11 questions, often and very often were the clinically significant symptom levels. See text for the rationale for this difference.
# The six-question ASRS screener.
the syndrome by the screening scale) ; specificity (the percent of respondents without the clinician-rated syndrome classified as not having the syndrome by the screening scale) ; total classification accuracy (the percent of all respondents consistently classified by the ASRS and clinician ratings) ; the odds ratio (OR) of the 2r2 table between yes-no syndrome classifications based on the ASRS and the clinical ratings; Cohen's k (a measure of concordance that adjusts for chance agreement) ; and the area under the receiver operator characteristic curve (AUC ; the probability that a randomly selected clinical case would score higher on the ASRS than a randomly selected non-case).
In order to investigate whether most of the precision of the full 18-question ASRS could be captured with fewer items, stepwise logistic regression analysis was used to select the best subset of ASRS questions to create a short-form screener. Only six questions were found to enter this stepwise analysis significantly. However, all-possible subsets logistic regression showed that a number of different six-question subsets of the 18 questions were roughly equivalent in reproducing clinical diagnoses. As a result, the psychometric analyses described in the last paragraph were repeated for all these alternative six-question short-form scales. Inspection of test statistics was used to select a final optimal shortform scale.
The conventional screening approach creates a dichotomy to differentiate predicted cases and non-cases. However, this dichotomization often discards potentially useful information that would be retained in a polychotomous screening scale, such as the distinction between a nearly definite case and a probable case. As a result, the use of polychotomous screening scales is becoming increasingly popular in evidencebased medicine (Peirce & Cornell, 1993) . In order to investigate whether this might be useful for the ASRS, polychotomous versions of both the optimal 18-question and six-question scoring methods were created.
As the sample design features clustering and weighting of cases, design-based methods were used to calculate standard errors and confidence intervals. The jackknife pseudo-replication method (Wolter, 1985) implemented in an SAS 8 macro (SAS Institute, 1999) was used to make these calculations.
RESULTS

Symptom-level concordance
In order to assess symptom-level concordance, the 0-4 ASRS response scale was collapsed into a dichotomy that mapped onto the dichotomous clinical ratings. The conventional way to do this is to select the same dichotomy for all questions, with responses of often or very often usually considered above the clinical threshold and other responses (never, rarely, and sometimes) below the threshold (e.g. O'Donnell et al. 2001) . However, this approach can lead to error either when the self-report questions vary in severity or when respondents are more reluctant to admit the frequent occurrence of some symptoms than others, in which case it is preferable to allow between-question variation in thresholds (Kessler et al. 2002) . Based on this thinking, the 2r5 cross-classification of each 0-4 ASRS response with the dichotomous clinical symptom rating was inspected and the ASRS response scale was dichotomized in such a way that the numbers of false positives (ASRS positives who were rated as asymptomatic in the clinical interview) and false negatives (ASRS negatives who were rated as having the symptom in the clinical interview) in the weighted data were as equal as possible. This rule resulted in clinically significant symptom levels being defined as those that occurred often or very often for 11 screening questions and as sometimes, often, or very often for the other seven screening questions.
Cohen's k was used to assess concordance between dichotomized ASRS symptom responses and clinical symptom ratings. Applying commonly used standards for assessing strength of k coefficients (Landis & Koch, 1977) , concordance was slight (less than 0 . 2) for two questions, fair (0 . 2-0 . 4) for seven, moderate (0 . 4-0 . 6) for six, and substantial (0 . 6-0 . 8) for the remaining three. Eleven of the 18 questions were found to be unbiased in the sense that the number of false positives did not differ significantly from the number of false negatives at the 0 . 05 level of significance using two-sided tests. The proportion of biased questions was comparable for inattention and hyperactivityimpulsivity. Three of the seven biased questions were biased downward and the other four were biased upward. Detailed results of these comparisons are included in the appendix materials posted at the website mentioned earlier in the paper.
Optimal scoring of the ASRS
The most direct mapping of ASRS responses onto DSM-IV Criterion A is to classify respondents as cases if they have positive responses either to six or more inattention questions or to six or more hyperactivity-impulsivity questions. However, as concordance between the ASRS questions and clinical symptom ratings is far from perfect, application of the six-of-nine rule might not be optimal in predicting clinical syndrome classifications. A total of six dimensional scoring methods were consequently applied to the data and concordance with the clinical syndrome classifications assessed for all dichotomizations of each of these six. The first three of the six scoring methods were based on separate scores for the inattention and the hyperactivityimpulsivity domains, with each respondent receiving the higher of these two scores.
The first method counted the number of positive symptom screens in each domain (one dichotomization of which is the DSM-IV six-ofnine categorization).
The second method assigned greater weight to responses of 'very often ' than to other positive responses and then counted the weighted number of positive symptom screens in each domain. A range of relative weights was considered here up to a maximum of 2 : 1.
The third method included the full 0-4 range of responses to the screening questions and summed these responses in each domain.
The fourth through sixth scoring methods were similar to the first three except that they were based on a summation across all 18 questions rather than on the higher score in the separate inattention and hyperactivity-impulsivity domains.
Test statistics are presented in Table 2 for the optimal dichotomous cut-point for each of these six scoring methods, where optimality is defined as minimization of the difference between false positive (FP) and false negative (FN). Method 4 is clearly the best one in this set, yielding the highest total classification accuracy (96 . 2 %), OR (73 . 4), k (0 . 58), and close to the highest AUC (0 . 77). While compared to Method 4, Method 3 has a marginally higher sensitivity (60 . 2% v. 56 . 3%) and AUC (78 v. 77). This is achieved at the expense of a lower specificity (96 . 3% v. 98 . 3%), resulting in lower total classification accuracy (94 . 5% v. 96 . 2%) and a dramatically lower OR (39 . 5 v. 73 . 4) for Method 3 than Method 4. Based on these considerations and the previously specified optimality criterion, Method 4 was selected as the optimal simple scoring method of the ASRS. The first three scoring methods calculated separate scores for the inattention and the hyperactivity-impulsivity domains and assigned the higher of these two scores. The first method counted the number of positive symptom screens (defined in Table 3 ) in each domain. The second method assigned greater weight to responses of ' very often ' than to other positive responses and then counted the weighted number of positive symptom screens in each domain, with a range of relative weights up to a maximum of 2 : 1. Only results of the 2 : 1 version are reported here. The third method included the full 0-4 range of responses to the ASRS questions and summed these responses separately for the inattention and hyperactivity-impulsivity domains. The fourth through sixth scoring methods were similar to the first three except that they were based on a summation across all 18 questions rather than on the higher score in the separate inattention and hyperactivity-impulsivity domains. In order to explore the usefulness of a polychotomous classification, the optimally-scored ASRS was collapsed into strata so that the probability of being classified as a clinical case did not differ meaningfully across cells within each stratum, but did differ meaningfully across strata. Three strata were found to meet these criteria, corresponding to scale scores in the range 0-3, 4-8, and 9-18. Part I of Table 3 shows the sensitivity and specificity for each stratum. Part II presents estimates of Positive predictive values (PPV) for plausible values of population prevalence. As shown in the first row of Part I, 56 . 3 % of adults in the general population who meet clinical criteria for ADHD are in the highest stratum, with 30 . 3 % in the middle stratum and the remaining 13 . 4 % in the lowest stratum. Nearly three-quarters (70 . 5%) of clinical non-cases are in the lowest ASRS stratum, 27 . 8% in the middle stratum, and only 1 . 7% in the highest stratum. Given that best estimates from available studies put the community prevalence of adult ADHD in the range 1-6 % (Wender et al. 2001) and prevalence in general medical populations as much as twice as high, the PPV of the three strata in population studies would be in the range 0 . 2-2 . 5% in the lowest stratum, 1 . 1-13 . 0 % in the middle stratum, and 24 . 8-81 . 7% in the highest stratum, if sensitivity and specificity were constant.
The ASRS screener
As an 18-question screening scale is too long for many purposes, we investigated whether we could develop a useful short-form screener.
Stepwise logistic regression was used to make this evaluation, beginning with the selection of the dichotomously coded screening questions that most accurately predicted the clinical syndrome classifications. An inspection of successive changes in AUC as new questions were added to the prediction equation was used to select an optimal number of questions, leading to the conclusion that six questions were the optimal number. The equation with this number of predictors had AUC=0 . 95 and x 6 2 =13 . 9 ( p=0 . 031). We then attempted to select additional predictors that distinguished between responses of very often and other positive responses. No significant predictors of this sort could be found (x 3 2 =1 . 4, p=0 . 702 for the three best predictors in this set). We then attempted to select additional predictors that added information on the full 0-4 range of responses, but again found no significant predictors of this sort (x 3 2 =0 . 2, p=0 . 978 for the three best predictors in this set).
Based on these results, further analysis focused on six-question screeners that used dichotomous symptom scoring. All-possiblesubsets logistic regression analysis showed that several six-question subsets had very similar values of AUC and x 2 in predicting clinical syndrome classifications. The concordance of these scales with clinical syndrome classifications was assessed for all logically possible dichotomizations. Test statistics showed one of these to be marginally superior to the rest in that it had close to the highest sensitivity (68 . 7%), the highest specificity (99 . 5 %), and the highest overall concordance as indicated by total classification accuracy (97 . 9%), OR (414 . 1), k (0 . 76), and AUC (0 . 84). Detailed results of these comparisons are included in the appendix materials posted at the website mentioned earlier in the paper.
As with the optimal 18-question version of the ASRS, the optimal six-question ASRS screener was collapsed into three strata (0-1, 2-3, and 4-6). Sensitivities and specificities for the strata are presented in Part I of Table 4 . Approximately two-thirds (68 . 7 %) of clinical cases scored in the highest stratum, with only 4 . 3 % in the lowest stratum. About threequarters of clinical non-cases (74 . 8%), in comparison, scored in the lowest stratum and only 0 . 5 % in the highest stratum. Part II of the table shows that PPVs of the three strata are in the range 0 . 1-0 . 8 for the lowest stratum, 1 . 1-3 . 0 for the middle stratum, and 56 . 8-94 . 7 for the highest stratum for plausible values of population prevalence. Comparing these PPVs with the distribution of sensitivities in Part I of the table shows that about one-third of clinical cases (i.e. those in the lowest and middle strata) would be missed with this screen, while twothirds in the highest stratum would be classified as having a very high probability of being cases.
ASRS discrimination among screener positives
Comparison of the results in Tables 3 and 4 shows that the six-question screener outperforms the full 18-question ASRS. However, two further results suggest that the full ASRS might nonetheless be useful among people who are positive on the screener. First, the percent of clinical cases screening positive on a dichotomous version of the full ASRS in which positives are defined as those scoring 11-18 (49 . 1%, with an S.E. of 11 . 0%) is significantly higher than the percent of clinical noncases screening positive on the same dichotomy (15 . 2%, with a S.E. of 12 . 4%, z=2 . 0, p=0 . 043), documenting that administration of the full ASRS can significantly improve classification of true cases among people who are positive on the six-question screener. Second, a substantial Pearson correlation (r=0 . 43, p<0 . 001) exists between a version of the ASRS that sums responses to the 18 ASRS questions using the full 0-4 response scale (generating a scale with a 0-72 range) and the scale of current clinical symptom severity, documenting that repeat administration of the full ASRS might be useful in charting clinical improvement among cases in treatment.
DISCUSSION
It is important to note that no data have ever been published on the validity of the clinical interview used as the gold standard in this study even though it has become the standard in clinical studies of adult ADHD (Spencer et al. 1995 (Spencer et al. , 1998 (Spencer et al. , 2001 Michelson et al. 2003) . To the extent that it imperfectly operationalizes the DSM-IV criteria, the validity of the ASRS might be underestimated. Another important boundary condition is that we developed the scale in an explicit attempt to equalize the (Kramer, 1992) . A potential limitation of the study design is that the self-report questions were administered after the completion of the clinical assessment, possibly resulting in some respondents becoming more sensitized to their symptoms and responding to the ASRS differently than they would have otherwise. This problem could be resolved in future face-to-face clinical reappraisal studies by having respondents selfadminister a paper and pencil version of the ASRS before blind administration of the clinical interview. Another limitation regarding validity is that all data are obtained from respondents rather than also from informants.
Methodological studies comparing adult self-reports versus informant reports of ADHD symptoms generally show the same pattern of disagreement as in studies of child self-reports versus informant reports (Jensen et al. 1999) ; namely, that informants report higher symptoms than respondents (Gittelman & Mannuzza, 1985 ; Zucker et al. 2002) . This suggests that both the clinical interviews and the ASRS results might be conservative. It is important to note, however, that the one adult self-versusinformant ADHD symptom comparison study that was carried out in a non-clinical sample found fairly strong associations between the two reports and no self-informant difference in reported symptom severity (Murphy & Schachar, 2000) .
An additional limitation is that a single set of scoring rules was presented even though the optimal thresholds and appropriate values of PPV might differ as a function of gender, educational status, marital status, or other known correlates of adult ADHD. No attempt was made to generate subsample scoring rules, however, based on the clinical reappraisal sample being too small for powerful subsample analysis. This small sample size also raises concerns about the generalizability of the results. This is especially true for the ASRS screener, which was developed based on the use of stepwise regression analysis and might have capitalized on chance in selecting items. It is worth noting, in this regard, that the variation in the symptom-level concordance between the ASRS and the clinical ratings could also have been taken into consideration in scoring by including question-level weights, such as those generated in a logistic regression analysis that regressed the dichotomous clinical syndrome classifications on the 18 separate ASRS questions. We decided against this, however, based on concern about over-fitting the data.
Within the context of these limitations, the results suggest that the six-question ASRS screener is a very good tool for reproducing the overall clinical evaluations made by carefully trained and closely monitored clinical interviewers. The three-stratum version of the scale, in particular, has excellent concordance with blind clinical diagnoses. This means that the transformation of the scale's stratum classifications into individual-level predicted probabilities of clinical diagnoses can be used in general population epidemiological surveys to generate an outcome variable that will be a good surrogate for clinical syndrome classifications.
In light of the evidence that the six-question ASRS screener out-performs the full ASRS, a question can be asked whether the latter has any value. As noted in the discussion of limitations, our scoring of the full ASRS was based on an unweighted summation of responses. A weighted version of the full scale might prove to have much greater concordance with clinical syndrome classifications than the screener, although it would be necessary to have a cross-validation sample to investigate this possibility rigorously. Furthermore, we showed that the full ASRS both refines prediction of the clinical classification among respondents who are positive on the six-question screener and correlates significantly with clinician-rated overall symptom severity in this same subsample.
The six-question ASRS screener, in comparison, seems to hold more promise than the full ASRS for clinical screening purposes. As shown in Table 4 , over two-thirds of clinical cases screen positive on the six-question screener compared to an extremely low proportion of non-cases (0 . 5%), resulting in a high proportion of screened positives being true cases under all plausible assumptions about the population prevalence of the disorder. The situation with the roughly one-third of clinical cases who are negative on the six-question ASRS screener is also important to consider. None of the scoring rules we considered was able to generate a stratum that could reliably distinguish these cases from non-cases. Not surprisingly, these screened negative clinical cases had an average clinical symptom severity score lower than clinical cases that screened positive (1 . 5 v. 1 . 8, z=1 . 7, p=0 . 091). More detailed analyses explored whether we could capture these false negatives by using information in the remaining 12 ASRS questions or in the additional 11 questions that were thought by the clinical experts to be other common expressions of adult ADHD. No evidence was found that the screening scale could be improved by using this additional information.
The probability of a person with a given score on a screening scale meeting criteria for a disorder (i.e. the PPV at that point on the scale) will have the same expected value in a given population as in a calibration sample only if the calibration sample is representative of that population. That is why estimates of PPV were reported for a range of plausible prevalence values. Importantly, we found that the PPV of the highest stratum in the ASRS screener is quite high even under the assumption of an implausibly low prevalence. We also found that the PPV of the middle stratum in the ASRS screener is quite low even under the assumption of a high prevalence. These results tell us that patients who screen into the highest stratum of the ASRS screener in primary care samples should routinely be considered likely cases who warrant further evaluation, while primary care patients who screen into the middle stratum should only be evaluated further when there is other evidence to suggest that they might be cases.
Uncertainty about PPV is of considerably more importance, in comparison, in epidemiological surveys that focus on segments of the population that cannot be considered representative of the total USA population. Although it is conventional to use standardized cut-points in such surveys, these can lead to substantial error in estimating prevalence and correlates. A less biased approach is to generate expected stratum distributions for all logically possible values of population prevalence (noting that the expected sample proportion in a given stratum is the sum of the products of prevalence times sensitivity and the additive inverse of prevalence times the additive inverse of specificity) based on the sensitivities and specificities reported in Table 4 and to use maximum-likelihood comparisons of these theoretical distributions with observed stratum distributions in the sample to select the most likely prevalence in the population from which the sample was selected. Once this maximum-likelihood prevalence estimate is obtained, individual-level predicted probabilities can be calculated easily (Guyatt & Rennie, 2001) .
Besides using the six-question ASRS screener in epidemiological surveys and in primary care screening, the good results about the precision of the screener and the fact that it can be self-administered easily and quickly (less than 2 minutes) might make it a useful secondary measure to include in clinical studies. This could be a useful complement to the dimensional clinical assessments of ADHD symptom severity typically used in such studies to define a lowerbound severity threshold that distinguishes community cases from non-cases (i.e. the highest versus middle strata in the ASRS screener). The use of the ASRS screener in clinical studies would also provide a useful crosswalk between clinical research and community epidemiological research by allowing a comparison of the severity distribution between community and clinical cases. The absence of such comparative data has restricted our ability to interpret the clinical significance of categorical prevalence estimates of most mental disorders in community epidemiological studies up to now (Kessler et al. in press) . The inclusion of identical short dimensional assessments of adult ADHD in both clinical and community studies would be a useful step in the direction of addressing this important problem for this heretofore understudied disorder.
